Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/01/25 → 30/04/29 |
Funding
- National Institute for Health Research: £61,940.12
- National Institute for Health Research: £3,201,038.38
- National Institute for Health Research: £3,201,038.38
LACunar Intervention (LACI) Trial-3: Assessment of efficacy and safety of cilostazol and isosorbide mononitrate to prevent adverse outcomes in patients with cerebral small vessel disease (lacunar) ischaemic stroke
- Wardlaw, Joanna (Principal Investigator)
- Stoddart, Andrew (Co-investigator)